The Impact of Limited Distribution Networks on Specialty Pharmacy

Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses how specialty pharmacies can navigate limited distribution networks.

Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses how specialty pharmacies can navigate limited distribution networks.

Related Content:

InterviewsReimbursementSpecialty Pharmacy
Treatment with Ofatumumab Increases Number of Patients Who Achieve No Evidence of Disease Activity for MS
Bringing Oncology Pharmacy Leaders, Payers Together to Address Unmet Educational Needs in the Field
Oncology Overview: Sonidegib (Odomzo) for Locally Advanced Basal Cell Carcinoma